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Abstract 
BACKGROUND: Obesity is a major risk factor for many diseases including cardiovascular 
diseases (CVDs). Recently, it has been shown that upper body obesity can predict CVDs per se. 
In this study, we aimed to determine the association between indicators of upper body obesity 
and echocardiographic indices. 
METHODS: In this cross-sectional study conducted in Hajar Hospital in Shahrekord, Iran, from 
March to August 2014, 80 healthy adults were included. Participants’ neck circumference (NC), 
waist circumference (WC), body mass index (BMI), and blood pressure were measured. 
Echocardiography was performed for all participants, and echocardiographic indices such as early 
(E’) and late (A') diastolic tissue velocity, early (E) and late (A) transmitral flow velocity, E/E’ ratio, 
pulmonary arterial pressure (PAP), and left atrial volume (LAV) were recorded. The association 
between these indices were investigated using bivariate Pearson correlation coefficient. 
RESULTS: For men, NC had a significant correlation with LAV, systolic blood pressure (SBP), 
diastolic blood pressure (DBP), PAP, and A', and a negative correlation with E′. WC had a 
significant correlation with LAV, SBP, and PAP, and a negative correlation with E′, while BMI 
had a significant correlation with LAV, PAP, SBP, A, and A’. For women, NC had a significant 
positive correlation with LAV, A, ejection fraction (EF), SBP, PAP, and A’, and a negative 
correlation with E′ and E/E′. WC had a significant positive correlation with LAV, DBP, PAP, A, 
A’, and a negative correlation with E′, while BMI had a significant correlation with LAV, EF, 
SBP, PAP, E’, A, and A’. 
CONCLUSION: The positive correlation of NC with SBP, A, and A', as well as NC, WC, and BMI 
with LAV and PAP in both sexes, and the negative correlation of NC with E′ show the 
importance of these measures in estimation of metabolic and cardiovascular risk factors. 
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Introduction 
Insight into echocardiographic parameters in the 
general population may facilitate early recognition 
of ventricular dysfunction, and reducing the 
population’s morbidity and mortality due to heart 
failure.1 Echocardiographic parameters can predict 
cardiovascular events in several clinical settings.2 
For decades, metabolic syndrome including obesity 
has been a major risk factor for cardiovascular 
diseases (CVDs).3 Recently, the results of 
observational studies have stated that upper body 
obesity has a significant association with CVD, 
hyperinsulinemia, diabetes mellitus (DM), and 
hypertriglyceridemia independently.4-7 It has been 
shown that upper body obesity is correlated with 
CVDs and metabolic syndrome more than general 
obesity and body mass index (BMI).8  
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There are many different ways to assess upper 
body obesity. Although imaging techniques such as 
magnetic resonance imaging (MRI), computed 
tomography (CT), and double X-ray are known as 
the best methods for estimation of upper body 
obesity, the excessive costs and adverse effects of 
radiation has disabled using them as appropriate 
screening methods. Thus, anthropometric 
measurements, such as measuring waist 
circumference (WC), waist to hip ratio, waist to 
height ratio, and neck circumference (NC), have 
been suggested as commonly-used simple and non-
invasive methods for estimation of upper body 
obesity.9-13 Evidence suggests NC as an independent 
indicator of upper body obesity, associated with 
metabolic syndrome factors and CVDs.14 As some 
studies have shown the variation of upper body 
obesity based on the population’s ethnicity and race 
for predicting DM and CVD,4 and this association 
has not been studied in Iranian population, in this 
study, we aimed to determine the association 
between upper body anthropometric measurements 
and cardiac diastolic dysfunction in people with 
normal ejection fraction (EF). 
Materials and Methods 
This cross-sectional study was performed in Hajar 
Hospital, Shahrekord, Iran, from March to August 
2014. Eighty participants were selected from those 
who referred to the cardiovascular clinics, only to 
accompany a patient. The participants’ age ranged 
from 35 to 50 years, and all were invited to the 
study after reading and signing the written informed 
consent form. Any patient with any of the following 
criteria was excluded from the study: sleep apnea, 
DM, neck deformity, lymphadenopathy, thyroiditis, 
thyromegaly, hypertension, left ventricular 
hypertrophy, EF < 50%, and valvular heart diseases. 
The participants’ demographic characteristics 
were recorded on the study checklist, including 
positive family history of cardiac disorders and risk 
factors (like DM, smoking, and hypertension). 
Participants’ height and weight were measured by the 
researcher with precision of 1 mm and 100 grams, 
respectively, while the person was wearing light 
clothing and no shoes; BMI was calculated by 
dividing weight (in kilograms) by squared height (in 
meters). The participants were asked to stand straight 
with their head positioning in Frankfort horizontal 
level, and a tape measure was placed right under 
laryngeal prominence around the neck in order to 
measure the NC. WC was measured while the 
participants stood up with no clothes, and a tape 
measure was placed between the last rib and the iliac 
crest. Systolic (SBP) and diastolic (DBP) blood 
pressures were measured using an oscillometric 
approach, and an appropriate cuff was used based on 
the participants’ right arm circumflex. Before 
measuring BP, all participants relaxed for at least 10 
minutes, and BP was measured only once. 
Echocardiography was performed using a Vivid 3 
Ultrasound Machine (cardiac ultrasound images). 
Cardiac function parameters such as EF, early diastolic 
mitral annular (E'), and late diastolic (A') velocities 
were measured by Doppler Tissue Imaging (DTI), and 
the E/E' ratio was computed. Recorded mitral inflow 
measurements included early mitral filling (E) and late 
(A) velocities, E/A ratio, deceleration time of E 
velocity, and duration of A.15 Left atrial volume (LAV) 
was also measured using prolate ellipse method (D1 × 
D2 × D3 × 0.523).16 Systolic pulmonary artery pressure 
(SPAP) was measured using tricuspid regurgitation 
and Bernoulli formula.16 All the measurements were 
performed by a single investigator and 
echocardiography assessments were carried out by a 
fixed individual cardiologist. 
All data were analyzed using SPSS software 
(version 20.0, IBM Corporation, Armonk, NY, 
USA). Numerical measurements were normally 
distributed and reported as mean ± standard 
deviation (SD). Two samples t test was used to 
compare mean differences of cardiac function 
parameters between men and women participants. 
Pearson correlation coefficient was calculated to 
evaluate association between anthropometric 
measures (NC and WC) and cardiac function 
parameters. To avoid multiplicity problem, 
Bonferroni correction was applied. P-values of less 
than 0.050 were considered statistically significant. 
Results 
Eighty subjects (54 women and 26 men) with mean 
(± SD) age of 40.0 (± 8.1) years participated in this 
study. None of the participants were a known case 
of CVDs or DM. The mean values of BMI, NC, 
WC, and BP are presented in table 1. Independent  
t test showed that the difference between the mean 
age and BMI of the women and men were not 
statistically significant (P > 0.050). But, there were 
significant differences between men and women in 
terms of other variables such as height and weight, 
NC, and WC (P < 0.050 for all). 
The correlation of NC, WC, and BMI with 
echocardiographic variables and BP was tested for 
men and women, and the results of which are shown 
in tables 2 and 3, respectively.  
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Table 1. The demographic characteristics of participants 
Variable Men (n = 26) Women (n = 54) Total (n = 80) P 
Age (year) 41.5 ± 7.3 39.2 ± 8.3 40.0 ± 8.1 0.227 
Height (cm) 171.8 ± 9.7 160.3 ± 6.1 40.0 ± 8.1 0.003 
Weight (kg) 82.3 ± 15.1 71.2 ± 12.7 40.0 ± 8.1 0.001 
NC (cm) 40.1 ± 3.4 35.6 ± 3.1 37.1 ± 3.8 0.023 
WC (cm) 94.9 ± 12.5 83.5 ± 11.5 87.2 ± 12.9 0.008 
SBP (mmHg) 120.9 ± 6.6 114.3 ± 7.5 116.5 ± 7.8 0.040 
DBP (mmHg) 80.7 ± 5.9 76.2 ± 5.5 77.7 ± 6.0 0.001 
BMI (kg/m
2
) 27.8 ± 4.4 27.7 ± 4.8 27.7 ± 4.6 0.879 
Data are reported as mean ± standard deviation (SD). 
NC: Neck circumference; WC: Waist circumference; SBP: Systolic blood pressure; DBP: Diastolic blood 
pressure; BMI: Body mass index 
 
According to table 2, for men, NC had a positive 
correlation with LAV, SBP, pulmonary arterial 
pressure (PAP), A', and DBP, and a negative 
correlation with E′. WC had a significantly positive 
correlation with LAV, SBP, and PAP, but a negative 
correlation with E′. BMI had a significantly positive 
correlation with LAV, PAP, SBP, A, and A’. 
According to table 3, for women, NC had a 
positive correlation with LAV, A, EF, SBP, PAP 
and A’ and a negative correlation with E′ and E/E′. 
WC had a significant correlation with LAV, DBP, 
PAP, A, and A’ and a negative correlation with E′. 
BMI had a significant positive correlation with PAP, 
E’, LAV, EF, SBP, A, and A’. 
Discussion 
The results of this study indicated that NC was 
significantly correlated with LAV, SBP, DBP, and 
PAP, which shows that all of them can be used as 
predictors of probable myocardial diastolic 
dysfunction. WC and BMI were also correlated with 
parameters, predicting the probability of myocardial 
dysfunction, but they both had a rather weaker 
correlation, compared to NC. Preis et al. showed 
that NC could be a marker of fat deposit, associated 
with great potential risk of CVDs.8 Ben-Noun and 
Laor also recognized the positive association 
between NC and some features of metabolic 
syndrome, predicting the risk of CVDs.14 The 
results of both studies are in line with that of ours.  
In our study, NC was associated with SBP and 
DBP. In previous studies, the relationship between 
NC and BMI or WC has been addressed in order to 
show the relation between NC and metabolic 
syndrome.4-8 Our study is in line with these 
statements, but adds the correlation of NC, another 
item of the metabolic syndrome, with SBP and 
DBP. This indicates that NC can be a potent 
criterion in metabolic syndrome and probable 
CVDs, which could be associated with the 
aforementioned matters. In our study, there was a 
strong negative correlation between NC and E', and 
a weak negative correlation between E' with WC 
and BMI, which shows that E' can be a better 
predictor for cardiac diastolic dysfunction than BMI 
and WC. 
 
Table 2. The correlation of neck circumference (NC), waist circumference (WC), and body mass index 
(BMI) with echocardiographic parameters in men 
Variable NC (cm) WC (cm) BMI (kg/m
2
) 
R P R P R P 
LAV (ml)  0.968 < 0.001 0.668 < 0.001 0.641 < 0.001 
EF (%) 0.060 0.298 -0.124 0.137 0.103 0.365 
SBP (mmHg) 0.442 < 0.001 0.387 < 0.001 0.291 0.009 
DBP (mmHg) 0.239 0.030 0.143 0.200 0.133 0.239 
PAP (mmHg) 0.777 < 0.001 0.679 < 0.001 0.500 < 0.001 
A (cm/s) 0.469 0.008 0.084 0.342 0.337 0.046 
A' (cm/s) 0.612 < 0.001 0.185 0.182 0.379 0.029 
E' (cm/s) -0.410 < 0.001 -0.383 < 0.001 -0.269 0.008 
E/E' -0.015 0.447 -0.024 0.416 0.088 0.437 
P-values of less than 0.050 were considered as statistically significant. 
NC: Neck circumference; WC: Waist circumference; BMI: Body mass index; LAV: Left atrial volume; EF: 
Ejection fraction; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; PAP: Pulmonary arterial 
pressure; A: Peak velocity of mitral inflow during atrial contraction, A′: Late diastolic mitral annular velocity, E: 
Peak velocity of mitral inflow during early filling phase; E′: Early diastolic mitral annular velocity 
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Table 3. The correlation of neck circumference (NC), waist circumference (WC), and body mass 
index (BMI) with echocardiographic parameters in women 
Variable NC (cm) WC (cm) BMI (kg/m
2
) 
R P R P R P 
LAV (ml)  0.935 < 0.001 0.541 0.008 0.722 0.030 
EF (%) 0.270 0.024 -0.120 0.465 0.277 0.021 
SBP (mmHg) 0.290 0.017 0.182 0.094 0.354 0.004 
DBP (mmHg) 0.134 0.167 0.143 0.024 0.136 0.164 
PAP (mmHg) 0.289 0.017 0.693 0.003 0.596 < 0.001 
A (cm/s) 0.555 < 0.001 0.446 0.002 0.472 0.002 
A' (cm/s) 0.589 0.030 0.489 0.003 0.372 0.003 
E' (cm/s) -0.382 < 0.001 -0.234 0.038 0.399 < 0.001 
E/E' -0.123 0.002 -0.075 0.294 0.207 0.067 
P-values of less than 0.050 were considered as statistically significant. 
NC: Neck circumference; WC: Waist circumference; BMI: Body mass index; LAV: Left atrial volume; EF: 
Ejection fraction; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; PAP: Pulmonary arterial pressure; 
A: Peak velocity of mitral inflow during atrial contraction, A′: Late diastolic mitral annular velocity, E: Peak 
velocity of mitral inflow during early filling phase; E′: Early diastolic mitral annular velocity 
 
For many years, BMI has been used to evaluate 
obesity, as a risk factor of CVDs. Also many studies 
have considered central obesity and WC as 
important markers for predicting CVDs.17-20 
Similarly, the results of our study confirmed the 
association between WC with different 
echocardiographic parameters and SBP. 
Looking to the whole picture reveals a stronger 
association between NC and echocardiographic 
parameters, compared to general obesity and WC. 
This is in line with studies that present upper body 
fat deposit as a better predictor of CVDs.6-22 
In our study, there was no significant correlation 
between NC and EF in neither sexes. This finding 
may be due to including only participants with EF of 
more than 50%. Thus, further studies are needed to 
evaluate the relation between NC and EF in 
participants with a wide range of EFs. Similarly, there 
was no significant correlation between NC and E/E' 
in men. The inclusion of participants with EF of more 
than 50% could be the reason for this finding; as E/E' 
is mainly impaired in advanced diastolic dysfunction, 
whereas in this study all cases were healthy, and no 
abnormality in E/E' ratio was expected. 
The cross-sectional study design is main 
drawback of our findings, as it is not possible to 
discuss the causal relationship between 
anthropometric indices and cardiac function. 
Furthermore, the fact that the studied participants 
came from a healthy population, could be either 
considered as a positive point or a limitation. Many 
patients with CVDs suffer from obesity and 
metabolic syndrome concurrently, and we excluded 
patients with CVD or DM to decrease the risk of 
bias in our study. On the other hand, such an 
inclusion criteria could be a limitation for studying 
the association between NC and some pathological 
features such as EF and E/E'. 
Conclusion 
In this study, it was observed that NC, WC, and BMI 
had a significant correlation with LAV and PAP, 
both in men and women. NC had a significant 
correlation with SBP in men and women, and also 
BMI had significant correlation with A in both sexes. 
These findings imply that these measures may help 
refine evaluations of metabolic and cardiovascular 
risk factors. Accordingly, regular NC, WC, and BMI 
screening is recommended as an easy and effective 
way of assessing body weight for prevention of 
weight-related diseases in men and women. 
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